Sign inGet started

LYCA

Lycia Therapeutics, Inc.CIK 1806540 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
$38.30M
11 trades · 1 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$38.30M
Insiders on file
10

AI insights for LYCA PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for LYCA
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

$35.22M2026-10-23 buys $1.37M 2026-10-23 sales —10-232026-10-26 buys $35.22M 2026-10-26 sales —10-262026-10-27 buys $1.06M 2026-10-27 sales —10-272026-10-28 buys $381.7K 2026-10-28 sales —10-282026-10-29 buys $26.3K 2026-10-29 sales —10-292026-10-30 buys $236.7K 2026-10-30 sales —10-30
■ Open-market buys (P)   ■ Open-market sales (S) · daily dollar value by transaction date

Insiders

InsiderRoleTradesBoughtSoldLast trade
Venrock Healthcare Capital Partners III, L.P.10% Owner14$38.30M$02026-10-30
Versant Ventures VII GP, L.P.10% Owner4$0$02026-10-26
Henderson JaneDirector2$0$02026-10-22
Fischer LaurentDirector2$0$02026-10-22
RIEFLIN WILLIAM JLDirector2$0$02026-10-22
Touami SofiaChief Business Officer1$0$02026-08-11
Staben StevenChief Scientific Officer, 10% Owner1$0$02026-08-11
Bachrodt AmyChief Financial Officer, 10% Owner1$0$02026-08-11
Lee Chin HyokChief Medical Officer, 10% Owner1$0$02026-08-11
Trombley Aetna WunPresident and CEO, Director, 10% Owner1$0$02026-08-11

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Venrock Healthcare Capital Par10% Owner P Buy2026-10-302026-10-30200$26.86 $5.4K6,850,237SEC↗
Venrock Healthcare Capital Par10% Owner P Buy2026-10-302026-10-308,804$26.27 $231.3K6,850,037SEC↗
Venrock Healthcare Capital Par10% Owner P Buy2026-10-292026-10-301,000$26.33 $26.3K6,841,233SEC↗
Venrock Healthcare Capital Par10% Owner P Buy2026-10-282026-10-304,430$25.97 $115.0K6,840,233SEC↗
Venrock Healthcare Capital Par10% Owner P Buy2026-10-282026-10-3010,570$25.23 $266.7K6,835,803SEC↗
Venrock Healthcare Capital Par10% Owner P Buy2026-10-272026-10-2731,067$26.84 $833.8K6,825,233SEC↗
Venrock Healthcare Capital Par10% Owner P Buy2026-10-272026-10-278,729$25.84 $225.6K6,794,166SEC↗
Versant Ventures VII GP, L.P.10% Owner C Conversion deriv2026-10-262026-10-286,284,597— —0SEC↗
Versant Ventures VII GP, L.P.10% Owner C Conversion deriv2026-10-262026-10-2825,390,410— —0SEC↗
Versant Ventures VII GP, L.P.10% Owner C Conversion2026-10-262026-10-281,393,882— —1,393,882SEC↗
Versant Ventures VII GP, L.P.10% Owner C Conversion2026-10-262026-10-285,631,425— —5,631,425SEC↗
Venrock Healthcare Capital Par10% Owner C Conversion deriv2026-10-262026-10-274,408,091— $00SEC↗
Venrock Healthcare Capital Par10% Owner C Conversion deriv2026-10-262026-10-2717,142,578— $00SEC↗
Venrock Healthcare Capital Par10% Owner P Buy2026-10-262026-10-278,261$26.97 $222.8K6,785,437SEC↗
Venrock Healthcare Capital Par10% Owner P Buy2026-10-262026-10-271,944,444$18.00 $35.00M6,777,176SEC↗
Venrock Healthcare Capital Par10% Owner C Conversion2026-10-262026-10-274,779,793— —4,832,732SEC↗
Venrock Healthcare Capital Par10% Owner P Buy2026-10-232026-10-2728,379$26.11 $741.0K52,939SEC↗
Venrock Healthcare Capital Par10% Owner P Buy2026-10-232026-10-2724,560$25.68 $630.7K24,560SEC↗
Henderson JaneDirector A Award deriv2026-10-222026-10-2620,000— $020,000SEC↗
Fischer LaurentDirector A Award deriv2026-10-222026-10-2620,000— $020,000SEC↗
RIEFLIN WILLIAM JLDirector A Award deriv2026-10-222026-10-2620,000— $020,000SEC↗
Henderson JaneDirector A Award deriv2026-08-112026-10-2657,666— $057,666SEC↗
Fischer LaurentDirector A Award deriv2026-08-112026-10-2613,307— $013,307SEC↗
Touami SofiaChief Business Officer A Award deriv2026-08-112026-10-2668,755— $068,755SEC↗
RIEFLIN WILLIAM JLDirector A Award deriv2026-08-112026-10-2624,840— $024,840SEC↗
Lee Chin HyokChief Medical Officer, 10% O A Award deriv2026-08-112026-10-2673,191— $073,191SEC↗
Staben StevenChief Scientific Officer, 10 A Award deriv2026-08-112026-10-26110,896— $0110,896SEC↗
Trombley Aetna WunPresident and CEO, Director, A Award deriv2026-08-112026-10-26443,586— $0443,586SEC↗
Bachrodt AmyChief Financial Officer, 10% A Award deriv2026-08-112026-10-26399,746— $0399,746SEC↗